Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Info
titleTU Domain Definition and Scope

...

titlecv.xpt
NamePR

...

Row

...

STUDYID

...

DOMAIN

...

USUBJID

...

PRTRT

...

VISIT

...

The transthoracic electrocardiography (TTE) produced images of the heart.

...

The Tumor/Lesion domains (TU, TR) represent data collected in clinical trials where sites of disease (e.g., tumors/lesions/locations of interest, lymph nodes, organs of interest in the assessment of the disease) are identified and then repeatedly measured/assessed at subsequent time points and often used in an evaluation of disease response(s).

Tumor/Lesion Identification (TU)


Dataset wrap
titlecv.xpt
NameTUPR


Dataset2


Row

STUDYID

DOMAIN

USUBJID

PRSEQ

PRTRT

VISIT

 1  ABCPR  ABC-4561TRANSTHORACIC ECHOCARDIOGRAPHYBASELINE




The below examples show the identification of calcification in the mitral valve annulus as well as mitral valve stenosis (TU). It also shows mitral valve regurgitation (CV).

Calcification Location Identification
Dataset wrap
titlecv.xpt
NameTU


Rowcaps


Rows 1-3:Examination of the heart indicates calcified mitral valve annulus and mitral valve stenosis.
Rows 4-5:Examination of the heart indicates regurgitation at the mitral valve, blood is regurgitating from the left ventricle
Rowcaps
Rows 1-2:I examined the TTE image of the heart (test location) and found calcified mitral valve annulus (result location).
Rows 3-4:I examined the TTE image of the heart (test location) and found that the mitral valve (result location) had become stenotic.
Rows 5-6:I examined the TTE image of the heart (test location) and regurgitation of blood in the mitral valve back into the left atrium.



hi1styleCalcification
Dataset2
aqua
hi12,4,6
tableidTU1


Row

STUDYID

DOMAIN

USUBJID

TUSEQ
TUGRPID
TULNKID
TULNKID
TUTESTCD

TUTEST

TULOC

TUORRES

TUSTRESCTURESLOCTURESLOC Detail

TUMETHOD

VISITNUM

VISIT

TUDTC

1ABCTUABC-4561
1CAL 1

LESIONIND

Lesion Indicator

HEARTY


TRANSTHORACIC ECHOCARDIOGRAPHY1BASELINE2020-04-27
2ABCTUABC-4562
1
mv calcification
CAL 1
ABNEXAMExamination for AbnormalityHEART
identified
Valvular CalcificationValvular CalcificationMitral Valve Annulus
TRANSTHORACIC ECHOCARDIOGRAPHY1BASELINE2020-04-27
3ABCTUABC-4563
mv stenosisABNEXAMExamination for AbnormalityHEARTValvular StenosisValvular StenosisMitral Valve
TRANSTHORACIC ECHOCARDIOGRAPHY1BASELINE2020-04-27




Dataset wrap
titlecv.xpt
NameCV



Y
Dataset2


Row

STUDYID

DOMAIN

USUBJID

CVSEQCVLNKIDCVTESTCD

CVTEST

CVLOC

CVORRES

CVSTRESCCVRESLOCCVRESLOC Detail

CVMETHOD

VISITNUM

VISIT

TUDTC

1ABCCVABC-4561

Abnormality Indicator

HEARTY


TRANSTHORACIC ECHOCARDIOGRAPHY1BASELINE2020-04-27
2ABCCVABC-4562mv regurgitationABNEXAMExamination for AbnormalityHEARTBlood RegurgitationBlood RegurgitationMitral ValveFrom left ventricle into the left atrium
2STEN 1Cardiac Valvular Stenosis IndicatorHEART
TRANSTHORACIC ECHOCARDIOGRAPHY1BASELINE2020-04-27




Alternatively modeling all of the above in CV:

Dataset wrap
titlecv.xpt
Namecv


Rowcaps


Rows 1-4:Examination of the heart indicates calcified mitral valve annulus and mitral valve stenosis, as well as regurgitation.
Rows 5-8:Show the various measurements of the regurgitant jet, which are used for the MV regurgitation severity assessment in RS.
Rows 9-11:Examination of the heart indicates flail aortic cusp and aortic valve stenosis, as well as regurgitation.
Rows 5-8:Show the various measurements of the regurgitant jet, which are used for the MV regurgitation severity assessment in RS.



Dataset2


Row

STUDYID

DOMAIN

USUBJID

CVSEQCVLNKIDCVGRPIDCVTESTCD

CVTEST

CVLOC

CVORRES

CVSTRESCCVSTRESNCVRESLOCCVRESLOC Detail

CVMETHOD

VISITNUM

VISIT

CVDTC

1ABC
TU
CVABC-456
42STEN 1Cardiac Valvular Stenosis Location IdentificationHEARTidentified
1

ABNIND

Abnormality Indicator

HEARTYYY

TRANSTHORACIC ECHOCARDIOGRAPHY1BASELINE2020-04-27
2ABCCVABC-4562
mvABNEXAMExamination for AbnormalityHEARTValvular CalcificationValvular CalcificationValvular CalcificationMitral Valve Annulus
TRANSTHORACIC ECHOCARDIOGRAPHY1BASELINE2020-04-27
3ABCCVABC-45631mvABNEXAMExamination for AbnormalityHEARTValvular StenosisValvular StenosisValvular StenosisMitral Valve
TRANSTHORACIC ECHOCARDIOGRAPHY1BASELINE2020-04-27
4ABCCVABC-45642mvABNEXAMExamination for AbnormalityHEARTBlood RegurgitationBlood RegurgitationBlood RegurgitationMitral ValveFrom left ventricle into the left atrium
Mitral Valve
TRANSTHORACIC ECHOCARDIOGRAPHY1BASELINE2020-04-27
5ABC
TU
CVABC-4565
3

av
REGUR 1Cardiac Valvular Regurgitation IndicatorHEART
ABNEXAMExamination for AbnormalityHEARTFlail CuspFlail CuspFlail Cusp

Aortic Valve, Right Coronary Cusp

Y


TRANSTHORACIC ECHOCARDIOGRAPHY1BASELINE2020-04-27
6ABC
TU
CVABC-45663
REGUR 1Cardiac Valvular Regurgitation Location IdentificationHEARTidentifiedMitral ValveInto the left atrium
avABNEXAMExamination for AbnormalityHEARTValvular StenosisValvular StenosisValvular StenosisAortic Valve
TRANSTHORACIC ECHOCARDIOGRAPHY1BASELINE2020-04-27
7ABCCVABC-45674avABNEXAMExamination for AbnormalityHEARTBlood RegurgitationBlood RegurgitationBlood RegurgitationAortic ValveFrom aorta to left ventricleTRANSTHORACIC ECHOCARDIOGRAPHY1BASELINE2020-04-27





The following example shows how to model severity assessments of the identified lesions and abnormalities based on peer-reviewed, validated and published instruments (either copyrighted or public domain). Note these tests were originally created as a CVTESTs, if users are using SDTMIG version versions prior to 3.4.  Per SDTMIG 3.4, this is now considered as a grading scale and therefore should now be represented as CC/RS.

Dataset wrap
NameRS


Rowcaps


Row 1:Mitral valve stenosis is moderate.
Row 2:Mitral valve regurgitation is severemoderate.
Rows 3-4:Aortic valve regurgitation and stenosis are mild.



Dataset2
Dataset wrap
NameTR
Dataset2


Row

STUDYID

DOMAIN

USUBJID

RSSEQTRLNKID

TRTEST

TRCAT

TRORRES

TRMETHOD

VISITNUM

VISIT

RSDTC

1ABCTRABC-4561CAL 1Calcification SeveritySponsor-defined CriteriaSevereTTE

Row

STUDYID

DOMAIN

USUBJID

RSSEQRSLNKID

RSTEST

RSCAT

RSORRES

VISITNUM

VISIT

RSDTC

1ABCRS(CC)ABC-4561REGUR 1VSC-Cardiac Valvular Stenosis Severity: Mitral ValveVALVE STENOSIS CLASSIFICATION 2009 VERSIONModerate1BASELINE2020-04-27
2ABCRS(CC)ABC-4562STEN 12SNVRC-Cardiac Valvular Regurgitation Severity: Mitral ValveSEVERITY OF NATIVE VALVULAR REGURGITATION CLASSIFICATION 2003SevereModerate1BASELINE2020-04-27

The below example shows how to represent calcification severity from a sponsor defined criteria using the TR domain. The Mitral Valve Annulus identified in TU is severely calcified.

Jordan: i originally mapped this to CV but this is an assessment of lesion severity, thusly can be considered as lesion properties? So I changed this dataset to TR instead. I seriously wonder whose idea it was to create a separate non-tumor lesion domain when everything on this page could have been mapped to the single CV domain (except the peer-reviewed, published clinical classifications). How do you expect users to know these details by just reading the SDTMIG?

3ABCRS(CC)ABC-45633VSC-Cardiac Valvular Stenosis Severity: Aortic ValveVALVE STENOSIS CLASSIFICATION 2009 VERSIONMild1BASELINE2020-04-27
4ABCRS(CC)ABC-45644SNVRC-Cardiac Valvular Regurgitation Severity: Aortic ValveSEVERITY OF NATIVE VALVULAR REGURGITATION CLASSIFICATION 2003Mild
1BASELINE2020-04-27






Attachments